AnalystsTara BancroftTara Bancroft's Stock Forecasts
AnalystsTara Bancroft
Sectors:
Analyst Ranking
Top 33%
#1735 out of 5331 analysts
Average Return
+30.49%
Win Rate
67%6 out of 9
Risk vs Reward
Poor
Good
Tara Bancroft's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Lantheus Holdings IncLNTH | +108.64% | $51.74 | $107.95 | 2025-09-15 - 2026-07-21 | Strong Buy |
Day One Biopharmaceuticals IncDAWN | +103.31% | $10.59 | $21.53 | 2026-01-13 - 2026-04-23 | Strong Buy |
Protagonist Therapeutics IncPTGX | +56.48% | $88.39 | $138.31 | 2026-02-26 - 2026-07-21 | Strong Buy |
Protagonist Therapeutics IncPTGX | +39.67% | $46.58 | $65.06 | 2024-09-24 - 2025-09-23 | Strong Buy |
Ocular Therapeutix IncOCUL | +37.01% | $6.08 | $8.33 | 2024-06-20 - 2025-06-18 | Strong Buy |
Tara Bancroft Analyst Color
Get additional color on Tara Bancroft's coverage of popular stocks
Tara Bancroft's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Protagonist Therapeutics IncPTGX | 2 | Strong Buy | $100.00 | -27.70% | Maintains | 5 months ago |
Day One Biopharmaceuticals IncDAWN | 1 | Strong Buy | $34.00 | +57.92% | Initiates Coverage On | 6 months ago |
Ocular Therapeutix IncOCUL | 4 | Strong Buy | $20.00 | +123.96% | Maintains | 9 months ago |
Lantheus Holdings IncLNTH | 1 | Strong Buy | $80.00 | -25.89% | Maintains | 10 months ago |
Tg Therapeutics IncTGTX | 1 | Strong Buy | $50.00 | N/A | Initiates Coverage On | 2 years ago |
Geron CorpGERN | 1 | Strong Buy | $10.00 | N/A | Initiates Coverage On | 2 years ago |
Bicycle Therapeutics PLCBCYC | 1 | Buy | N/A | N/A | Initiates Coverage On | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.